XML 52 R32.htm IDEA: XBRL DOCUMENT v3.22.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2021
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

For 2021, 2020, and 2019, the fair value of each option grant was estimated using the Black-Scholes option-pricing model, using the following assumptions:

Years Ended December 31, 

    

2021

    

2020

    

2019

Expected option life (years)

5.50 - 6.25

5.50 - 6.25

5.50 - 6.25

Risk-free interest rate

 

0.68% - 1.39%

  

0.31% - 1.63%

 

1.91% - 2.58%

Expected stock price volatility

 

48.2% - 49.5%

  

49.2% - 51.2%

 

63.1% - 66.7%

Dividend yield

 

 

Summary of Stock option and restricted stock activity

A summary of stock option activity under the 2008 Plan and Inducement Grants during the years ended December 31, 2021, 2020, and 2019 is presented below:

    

    

    

Weighted

    

Weighted

    

Average

Average

Weighted

Grant-

Remaining

(in thousands, except per share and

Option

Average

date

Term

Aggregate

remaining term data)

Shares

Exercise Price

Fair Value

(years)

Intrinsic Value

Outstanding December 31, 2018

 

759

$

49.74

 

7.6

$

2,221

Granted

 

160

 

65.97

$

40.14

Exercised

 

(130)

 

41.99

 

3,335

Forfeited

 

(31)

 

56.66

Expired

 

(1)

 

54.36

Outstanding December 31, 2019

 

757

$

54.21

 

7.2

$

6,761

Granted

 

231

 

30.29

$

14.39

Exercised

 

(8)

 

36.81

 

216

Forfeited

 

(44)

 

54.54

Expired

 

 

Outstanding at December 31, 2020

 

936

$

48.44

 

7.1

$

372

Granted

 

168

 

33.09

$

15.71

Exercised

 

(42)

 

40.25

 

552

Forfeited

 

(19)

 

59.84

Expired

 

(55)

 

55.59

Outstanding at December 31, 2021

 

988

$

45.56

 

6.6

$

6,786

Exercisable at December 31, 2021

 

613

$

51.60

 

5.3

$

1,994

Non-vested Restricted Stock Shares Activity

A summary of RSA activity under the Plan during the years ended December 31, 2021, 2020, and 2019 is presented below:

    

    

Weighted

    

Average Grant

Weighted Average

(in thousands, except per share and

Date Fair

Remaining Term

remaining term data)

Shares

Value

(years)

Unvested at December 31, 2018

 

117

$

54.04

 

2.1

Granted

 

122

 

66.39

 

  

Vested

 

(42)

 

54.77

 

  

Forfeited

 

(5)

 

62.63

 

  

Unvested at December 31, 2019

 

192

$

61.46

 

2.6

Granted

 

305

 

44.42

 

  

Vested

 

(127)

 

58.88

 

  

Forfeited

 

(18)

 

51.53

 

  

Unvested at December 31, 2020

 

352

$

48.14

 

2.7

Granted

 

541

 

33.02

 

  

Vested

 

(125)

 

48.32

 

  

Forfeited

 

(61)

 

48.16

 

  

Unvested at December 31, 2021

 

707

$

36.52

 

2.8

Employee Stock Purchase Plan 2016 [Member]  
Summary of allocated expense

(in thousands)

Years Ended December 31, 

    

2021

    

2020

    

2019

Cost of sales

$

15

$

21

$

18

Research and development

 

21

 

36

 

29

Selling, general, and administrative

 

87

 

123

 

100

$

123

$

180

$

147

Stock Incentive Plan 2008 [Member]  
Summary of allocated expense

Years Ended December 31, 

(in thousands)

    

2021

    

2020

    

2019

Cost of sales

$

5

$

115

$

101

Research and development

 

543

 

561

 

756

Selling, general, and administrative

 

9,818

 

12,080

 

8,213

$

10,366

$

12,756

$

9,070